Lucas & Mercanti, LLP Names Two New Partners and Counsel, Expands Pharmaceutical Litigation Practice

– David J. Galluzzo and Steven D. Roth Join the Firm as Partners, Dr.
Irving Feit as Of Counsel, Bringing Practical Scientific and Engineering
Experience to the Firm’s Growing Intellectual Property Litigation
Practice –

NEW YORK–(BUSINESS WIRE)–#law–David J. Galluzzo and Steven D. Roth have joined Lucas & Mercanti, LLP,
a boutique intellectual property law firm based in New York City, as
partners. Irv Feit, Ph.D., has joined as Of Counsel. The exciting
expansion speaks directly to their growing pharmaceutical litigation
practice.

“We are delighted to bring on board three extremely talented individuals
who bring unique experience to our firm,” says Michael Mercanti, Senior
Partner. “The industry is shifting. Clients want big law experience
without paying the price big law demands. These attorneys can challenge
the biggest firms,” he says. “In addition to their trial experience,
they have decades of in-house experience.” David was a research
scientist at Pfizer, Steven was general counsel at Hi-Tech Pharmacal,
and Irv was a vice president at ImClone Systems.

“This practical corporate experience provides perspective that most
lawyers do not have,” adds Mercanti. “The ability to switch hats between
scientists, in house personnel and litigators enables us to understand
our clients’ legal and business issues from their viewpoints. It is
truly a powerful combination of skills allowing us to efficiently
perform at the highest level.”

David Galluzzo joined the firm as a partner in January. He is a trial
and transactional attorney whose legal, business, and scientific careers
span two decades. David’s diverse practice includes representing both
branded and generic pharmaceutical companies in Hatch-Waxman and other
patent infringement actions; representing clients in Inter Partes Review
(IPR) proceedings before the Patent Trial and Appeal Board; drafting
trademark and patent applications; and providing freedom-to-operate,
invalidity and non-infringement opinions. David’s clients include those
in the fields of data science, arts and entertainment, and manufacturing.

Galluzzo is also the author of legal treatise "Qualifying
and Attacking Expert Witnesses”. Before his legal career, David was
a research scientist at Pfizer, Inc. where he synthesized pharmaceutical
compounds for the treatment of cardiovascular and metabolic diseases.

Steven Roth joined as a partner in February. His practice focuses on
patent litigation and prosecution in the pharmaceutical, biotech,
chemical and mechanical arts. Previously he was Associate General
Counsel and sole in-house attorney at Hi-Tech Pharmacal where he oversaw
and participated in the company’s lawsuits and pre-suit investigations,
including patent, trademark, class action, fraud, and contract
litigation. Steve was also responsible for regulatory compliance.

Roth has considerable trial experience, particularly in patent cases. He
has litigated multiple cases for Pfizer, Sanofi-Aventis, Hi-Tech/ Akorn,
winning multiple favorable judgments or settlements. Prior to law
school, Mr. Roth was a software engineer in the Aerospace industry at
Singer-Kearfott.

Irv Feit, Ph.D. joined the firm as Of Counsel in January. He specializes
in chemical and biotech patent law, including drafting and prosecuting
patent applications; post-patent procedures; providing opinions in
matters relating to portfolio strength, infringement, and validity for a
variety of large and small chemical and biotechnology companies, as well
as for investment bankers. He also has extensive experience negotiating
and drafting patent licenses and related agreements. He has appeared as
an expert witness during litigation.

Feit has served as in-house counsel Lever Brothers, Ciba-Geigy
Corporation, and was Vice President for Intellectual Property and
Licensing at ImClone Systems. He has a Ph.D. in organic chemistry, and
was among the first biotechnology patent practitioners in the United
States. Before attending law school, he was a research fellow at the
University of California and Associate Professor of Chemistry at LIU –
Post. He is the author or co-author of ten peer-reviewed papers in
organic chemistry and gave numerous presentations at professional
chemistry conferences.

About Lucas & Mercanti, LLP
Lucas
& Mercanti, LLP is a boutique intellectual property law firm
based in New York City. The firm, which can trace its roots to the
1930s, is renowned for attorneys with exceptionally strong and diverse
backgrounds devoted to providing big law expertise with boutique firm
values. Our services span the spectrum of intellectual property matters,
and include litigation, prosecution, appeals, interferences, licensing,
opinions, due diligence, IPRs and other post-grant patent challenges.
Many of our intellectual property lawyers have advanced scientific,
engineering, and technological degrees, giving them highly sought-after
expertise and coveted insight. Lucas & Mercanti contributes to our
clients’ success by understanding their business, representing them
proactively, and being efficient, responsive, and easy to work with.
Please contact us at (212) 661-8000 or visit http://www.lmiplaw.com.

Contacts

Lucas & Mercanti, LLP
Chris Prendergast, 212-661-8000